8-K filing — ENDRA Life Sciences Inc. (NDRA)
Filed: 2026-10-01 AccNo: 0001213900-26-105899 Size: 352 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
ENDRA Life Sciences Q2 EPS $0.06 Beats $(0.84) Estimate
ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.84) by 107.14 percent. This is a 103.51 percent increase over losses of $(1.71) per share
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading